ARCHIVES

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

This article is from The Cancer Letter archive.

Vol. 07 No. 43 | October 23, 1981

Download PDF Visit The Full Archive

Related Articles

Medicine Branch In Quick Recovery Under Meyers After Big Turnover

August 26, 1988

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Program Announcement Completes NCI switch To Control Research

April 16, 1982

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

February 26, 1999